Vivo Capital
company
Investments
Number of Investments
Number of Lead Investments
16
4
Vivo Capital has made 16 investments. Their most recent investment was on
Nov 29, 2022, when Rgenta Therapeutics, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Nov 29, 2022 | Rgenta Therapeutics | Series A | — | Biotechnology | — |
| Oct 27, 2022 | Neocis | Series D | — | Dental | — |
| Jul 6, 2022 | Tebra | Series B | — | Electronic Health Record (EHR) | — |
| May 25, 2021 | Rgenta Therapeutics | Seed | — | Biotechnology | — |
| May 6, 2021 | Aerobiotix | Series Unknown | — | Health Care | Yes |
| Jan 5, 2021 | Terns Pharmaceuticals | Series C | — | Biotechnology | — |
| Oct 8, 2020 | Neocis | Series D | — | Dental | — |
| Sep 4, 2019 | Passage Bio | Series B | — | Biotechnology | — |
| Feb 15, 2019 | Passage Bio | Series A | — | Biotechnology | — |
| Oct 30, 2018 | Terns Pharmaceuticals | Series B | — | Biotechnology | Yes |
| Nov 27, 2017 | Medeor Therapeutics | Series B | — | Biotechnology | — |
| Aug 3, 2017 | Amyris | Post-IPO Equity | — | Biotechnology | Yes |
| Apr 13, 2016 | Kala Pharmaceuticals | Series C | — | Biotechnology | — |
| Nov 6, 2013 | Ocera Therapeutics | Post-IPO Equity | — | Biopharma | — |
| Apr 15, 2011 | Eiger BioPharmaceuticals | Series A | — | Biotechnology | — |
| Feb 25, 2009 | Eiger BioPharmaceuticals | Series A | — | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
